Affiliation:
1. Pennsylvania State University, USA
Abstract
With rising costs of drug testing and more stringent requirements, Western countries have been increasingly outsourcing their drug trials. While such actions make sense from a cost-benefit point of view, can we conclude the same from a marketing-ethics perspective? Are these lesser-developed countries being held to the same ethical standards and practices as expected in the Western countries? Are the drug companies' actions somehow influencing the research participants' decision to partake in such trials? The author applies the theory of reasoned action and ethical marketing underpinnings to develop relevant propositions. Consequently, drug testing companies, research participants, and marketing agencies can utilize these propositions to investigate whether more rigorous oversight is required to protect research participants.
Reference109 articles.
1. Motivation for participation in clinical trials of drugs for the treatment of asthma, seasonal allergic rhinitis, and perennial nonallergic rhinitis
2. Pharmaceutical drug promotion practices in Pakistan: Issues in ethical and non-ethical pharmaceutical practices.;R. R.Ahmed;Middle East Journal of Scientific Research,2014
3. AjzenI.FishbeinM. (1980). Understanding attitudes and predicting social behavior. Prentice Hall Inc.
4. Challenges of conducting clinical trials in Asia.;S.Ali;International Journal (Toronto, Ont.),2018
5. American Marketing Association. (2020). https://www.ama.org/AboutAMA/Pages/Definition-of-Marketing.aspx